Skip to main content

Intelligent Bio Solutions Inc.

INBS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001725430

No open-market purchases or sales by Intelligent Bio Solutions Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $416.2K in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding Intelligent Bio Solutions Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of INBS: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders914+5
Shares241.8K533.7K+291.9K (+120.7%)
Value$347.0K$416.0K+$69.0K (+19.9%)

New holders (8)

Institutions that held Intelligent Bio Solutions Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to INBS in Q1 2022
InstitutionSharesValue% of portfolio
Geode Capital Management, LLC113,118$88.0K0.00%
Virtu Financial LLC89,394$70.0K0.01%
Renaissance Technologies LLC67,500$53.0K0.00%
Goldman Sachs Group Inc42,800$33.0K0.00%
Citadel Advisors LLC29,422$23.0K0.00%
Millennium Management LLC28,484$22.0K0.00%
IHT Wealth Management, LLC20,000$16.0K0.00%
State Street Corp10,515$8.00K0.00%

Sold out (3)

Institutions that held Intelligent Bio Solutions Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of INBS in Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
WealthShield Partners, LLC49,147$71.0K
Vanguard Group Inc38,925$56.0K
Jane Street Group, LLC25,184$36.0K